Derivatives (Schedule Of Derivative Activity For Derivatives Designated As Cash Flow Hedges) (Detail) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010
Derivative [Line Items]
Gain/(Loss) Reclassified from AOCI into Income (Effective Portion)	$ 10,894	$ (34,821)	$ (652)
Gain/(Loss) Recognized in Income on Derivatives (Ineffective Portion)	(7)	12	6
Gain/(Loss) from Amounts Excluded from Effectiveness Testing	(4,256)	(315)	(212)
Gain/(Loss) Recognized in AOCI (Effective Portion)	79,370	(82,270)	26,984
Foreign Exchange Contracts [Member]
Derivative [Line Items]
Gain/(Loss) Recognized in AOCI (Effective Portion)	79,819	(82,165)	27,967
Foreign Exchange Contracts [Member] | Cost of Sales [Member]
Derivative [Line Items]
Gain/(Loss) Reclassified from AOCI into Income (Effective Portion)	10,932	(34,063)	(2,028)
Gain/(Loss) Recognized in Income on Derivatives (Ineffective Portion)	0	0	0
Gain/(Loss) from Amounts Excluded from Effectiveness Testing	2	15	19
Foreign Exchange Contracts [Member] | SG&A [Member]
Derivative [Line Items]
Gain/(Loss) Reclassified from AOCI into Income (Effective Portion)	586	0	2,203
Gain/(Loss) Recognized in Income on Derivatives (Ineffective Portion)	0	0	0
Gain/(Loss) from Amounts Excluded from Effectiveness Testing	0	0	0
Foreign Exchange Contracts [Member] | Foreign Exchange Losses, Net [Member]
Derivative [Line Items]
Gain/(Loss) Reclassified from AOCI into Income (Effective Portion)	0	0	0
Gain/(Loss) Recognized in Income on Derivatives (Ineffective Portion)	0	21	14
Gain/(Loss) from Amounts Excluded from Effectiveness Testing	(4,258)	(330)	(231)
Interest Rate Swap [Member]
Derivative [Line Items]
Gain/(Loss) Recognized in AOCI (Effective Portion)	(449)	(105)	(983)
Interest Rate Swap [Member] | Selling General And Administrative Expense [Member]
Derivative [Line Items]
Gain/(Loss) Reclassified from AOCI into Income (Effective Portion)	(624)	(758)	(827)
Gain/(Loss) Recognized in Income on Derivatives (Ineffective Portion)	(7)	(9)	(8)
Gain/(Loss) from Amounts Excluded from Effectiveness Testing	$ 0	$ 0	$ 0